Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Walden Biosciences Announces Presentation at Antibody Engineering and Therapeutics Conference 2022

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Walden Biosciences

Immutep to Participate in The JMP Securities Hematology and Oncology Summit

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Immutep Limited

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Oyster Point Pharma, Inc.

Vaxxinity Announces Positive Topline Pivotal Phase 3 COVID-19 Booster Data for UB-612

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Vaxxinity, Inc.

VYNE Therapeutics to Participate in Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  VYNE Therapeutics Inc.

EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Novartis AG | Novan, Inc.

BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  BetterLife Pharma Inc.

STRATA Skin Sciences to Participate at Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  STRATA Skin Sciences, Inc.

Lantern Pharma to Participate at the RHK Capital Disruptive Growth Conference on December 5 at 12:00 p.m. ET

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Lantern Pharma Inc.

Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Xenon Pharmaceuticals Inc.

AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  AnaptysBio, Inc.

Chiesi USA Sponsors ASHP Advantage Initiative to Support Pharmacy Technician Recruitment and Retention

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Chiesi USA, Inc.

SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development

Read more ››
By: GlobenewsWire - 02 Dec 2022

Celldex Therapeutics Announces Multiple Upcoming Presentations of Barzolvolimab Data at GA²LEN Global Urticaria Forum (GUF) 2022

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Celldex Therapeutics, Inc.

Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Ovid Therapeutics Inc.

Result of AGM

Read more ››
By: GlobenewsWire - 02 Dec 2022

Nasdaq Iceland Approves the Request for Trading of Alvotech’s Shares on the Main Market

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Alvotech

AIM ImmunoTech Announces Abstract Accepted for Poster Presentation at the British Society for Immunology Congress 2022

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  AIM ImmunoTech Inc.

Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Biocartis Group NV

Press release Biocartis Group NV: Disclosure of a transparency notification

Read more ››
By: GlobenewsWire - 02 Dec 2022
Related companies:  Biocartis Group NV
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Click to get started »